Our world-class clinical researchers are leading the way in the discovery of newer and more effective therapies. As experts in tailoring radiation therapy uniquely to each patients’ cancer, we are 100% committed to providing the most up-to-date, personalized treatment to generate the best outcomes possible for our patients.
Our cutting-edge research program includes both clinical research and basic (laboratory) research. Our research often involves collaboration with other departments, as we strive to better identify and treat cancer and develop ways to deliver higher doses of radiation to the tumor area while reducing the effects on the surrounding healthy tissue.
Learn about our Biological/Translational Research
Learn about our Physics Research
Clinical Trials
We are engaged in hundreds of clinical trials that push the edges of scientific knowledge and offer patients novel treatment approaches. Clinical trials are scientific studies in which new treatments – drugs, diagnostic procedures and other therapies – are tested in patients to determine if they are safe and effective. These trials help scientists answer questions about new cancer therapies, such as what diseases they should be used for, what doses of new drugs are most effective, and which patients can benefit most from them. Nearly all cancer drugs in use today were tested and made available to patients through clinical trials.
Learn what it means to participate in a clinical trial and to search for ongoing clinical trials through the Dana-Farber Brigham Cancer Center and affiliated institutions.
See a list of early phase clinical trials for pediatric cancers.
BROADBAND Protocol
Patients who wish to contribute to scientific discoveries that will fuel future breakthroughs in the fight against cancer are invited to participate in BROADBAND (BWH Radiation Oncology All-Department Biorepository to Accelerate New Discoveries). This initiative collects blood and tissue samples and health information in partnership with the Biobank. Our researchers use this information about individual biological variations to develop new tests and treatments for patients with cancer. Our goal is to identify the most effective and safe therapies tailored to each patient.
